Network pharmacology integrated with experimental validation to elucidate the mechanisms of action of the Guizhi-Gancao Decoction in the treatment of phenylephrine-induced cardiac hypertrophy

References

• Bertero E, Maack C. 2018. Metabolic remodelling in heart failure. Nat Rev Cardiol. 15(8):457–470. doi:10.1038/s41569-018-0044-6.
   PubMed Web of Science ®Google Scholar
• Boknik P, Eskandar J, Hofmann B, Zimmermann N, Neumann J, Gergs U. 2020. Role of cardiac A2A receptors under normal and pathophysiological conditions. Front Pharmacol. 11:627838. doi:10.3389/fphar.2020.627838.
   PubMed Web of Science ®Google Scholar
• Bousquenaud M, Maskali F, Poussier S, Zangrando J, Marie PY, Boutley H, Fay R, Karcher G, Wagner DR, Devaux Y. 2013. Cardioprotective effects of adenosine within the border and remote areas of myocardial infarction. EJNMMI Res. 3(1):65. doi:10.1186/2191-219X-3-65.
   PubMedGoogle Scholar
• Braile M, Marcella S, Cristinziano L, Galdiero MR, Modestino L, Ferrara AL, Varricchi G, Marone G, Loffredo S. 2020. VEGF-A in cardiomyocytes and heart diseases. Int J Mol Sci. 21(15):5294. doi:10.3390/ijms21155294.
   PubMed Web of Science ®Google Scholar
• Burnstock G, Pelleg A. 2015. Cardiac purinergic signalling in health and disease. Purinergic Signal. 11(1):1–46. doi:10.1007/s11302-014-9436-1.
   PubMed Web of Science ®Google Scholar
• Castro CM, Corciulo C, Solesio ME, Liang F, Pavlov EV, Cronstein BN. 2020. Adenosine A2A receptor (A2AR) stimulation enhances mitochondrial metabolism and mitigates reactive oxygen species-mediated mitochondrial injury. FASEB J. 34(4):5027–5045. doi:10.1096/fj.201902459R.
   PubMed Web of Science ®Google Scholar
• Chang Z, Zhang Q, Feng Q, Xu J, Teng T, Luan Q, Shan C, Hu Y, Hemmings BA, Gao X, et al. 2010. Deletion of Akt1 causes heart defects and abnormal cardiomyocyte proliferation. Dev Biol. 347(2):384–391. doi:10.1016/j.ydbio.2010.08.033.
   PubMed Web of Science ®Google Scholar
• Chen HH, Zhao P, Tian J, Guo W, Xu M, Zhang C, Lu R. 2017. The Effects of guizhi gancao decoction on pressure overload-induced heart failure and posttranslational modifications of tubulin in mice. Evid Based Complement Alternat Med. 2017:2915247–2915248. doi:10.1155/2017/2915247.
   PubMed Web of Science ®Google Scholar
• Ding Y, Qiu L, Zhao G, Xu J, Wang S. 2010. Influence of cinnamaldehyde on viral myocarditis in mice. Am J Med Sci. 340(2):114–120. doi:10.1097/MAJ.0b013e3181dd3b43.
   PubMed Web of Science ®Google Scholar
• Dorri M, Hashemitabar S, Hosseinzadeh H. 2018. Cinnamon (Cinnamomum zeylanicum) as an antidote or a protective agent against natural or chemical toxicities: a review. Drug Chem Toxicol. 41(3):338–351. doi:10.1080/01480545.2017.1417995.
   PubMed Web of Science ®Google Scholar
• Effendi WI, Nagano T, Kobayashi K, Nishimura Y. 2020. Focusing on adenosine receptors as a potential targeted therapy in human diseases. Cells. 9(3):785. doi:10.3390/cells9030785.
   PubMed Web of Science ®Google Scholar
• Feldman AM, Combes A, Wagner D, Kadakomi T, Kubota T, Li YY, McTiernan C. 2000. The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol. 35(3):537–544. doi:10.1016/s0735-1097(99)00600-2.
   PubMed Web of Science ®Google Scholar
• Fu Y, Zhou H, Wang S, Wei Q. 2014. Glycyrol suppresses collagen-induced arthritis by regulating autoimmune and inflammatory responses. PLoS One. 9(7):e98137. doi:10.1371/journal.pone.0098137.
   PubMed Web of Science ®Google Scholar
• Gan XT, Rajapurohitam V, Haist JV, Chidiac P, Cook MA, Karmazyn M. 2005. Inhibition of phenylephrine-induced cardiomyocyte hypertrophy by activation of multiple adenosine receptor subtypes. J Pharmacol Exp Ther. 312(1):27–34. doi:10.1124/jpet.104.073122.
   PubMed Web of Science ®Google Scholar
• Gao Y, Song G, Cao YJ, Yan KP, Li B, Zhu XF, Wang YP, Xing ZY, Cui L, Wang XX, et al. 2019. The guizhi gancao decoction attenuates myocardial ischemia-reperfusion injury by suppressing inflammation and cardiomyocyte apoptosis. Evid Based Complement Alternat Med. 2019:1947465–1947411. doi:10.1155/2019/1947465.
   PubMed Web of Science ®Google Scholar
• Gaudry M, Vairo D, Marlinge M, Gaubert M, Guiol C, Mottola G, Gariboldi V, Deharo P, Sadrin S, Maixent JM, et al. 2020. Adenosine and its receptors: an expected tool for the diagnosis and treatment of coronary artery and ischemic heart diseases. Int J Mol Sci. 21(15):5321. doi:10.3390/ijms21155321.
   PubMed Web of Science ®Google Scholar
• Ghai G, Francis JE, Williams M, Dotson RA, Hopkins MF, Cote DT, Goodman FR, Zimmerman MB. 1987. Pharmacological characterization of CGS 15943A: a novel nonxanthine adenosine antagonist. J Pharmacol Exp Ther. 242(3):784–790.
   PubMed Web of Science ®Google Scholar
• Groenewegen A, Rutten FH, Mosterd A, Hoes AW. 2020. Epidemiology of heart failure. Eur J Heart Fail. 22(8):1342–1356. doi:10.1002/ejhf.1858.
   PubMed Web of Science ®Google Scholar
• Guerrero A. 2018. A2A Adenosine receptor agonists and their potential therapeutic applications. an update. Curr Med Chem. 25(30):3597–3612. doi:10.2174/0929867325666180313110254.
   PubMed Web of Science ®Google Scholar
• Headrick JP, Ashton KJ, Rose’meyer RB, Peart JN. 2013. Cardiovascular adenosine receptors: expression, actions and interactions. Pharmacol Ther. 140(1):92–111. doi:10.1016/j.pharmthera.2013.06.002.
   PubMed Web of Science ®Google Scholar
• Headrick JP, Peart JN, Reichelt ME, Haseler LJ. 2011. Adenosine and its receptors in the heart: regulation, retaliation and adaptation. Biochim Biophys Acta. 1808(5):1413–1428. doi:10.1016/j.bbamem.2010.11.016.
   PubMed Web of Science ®Google Scholar
• Hers I, Vincent EE, Tavaré JM. 2011. Akt signalling in health and disease. Cell Signal. 23(10):1515–1527. doi:10.1016/j.cellsig.2011.05.004.
   PubMed Web of Science ®Google Scholar
• Hopkins AL. 2007. Network pharmacology. Nat Biotechnol. 25(10):1110–1111. doi:10.1038/nbt1007-1110.
   PubMed Web of Science ®Google Scholar
• Hopkins AL. 2008. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 4(11):682–690. doi:10.1038/nchembio.118.
   PubMed Web of Science ®Google Scholar
• Hsin KY, Ghosh S, Kitano H. 2013. Combining machine learning systems and multiple docking simulation packages to improve docking prediction reliability for network pharmacology. PLoS One. 8(12):e83922. doi:10.1371/journal.pone.0083922.
   PubMed Web of Science ®Google Scholar
• Ismail BS, Mahmoud B, Abdel-Reheim ES, Soliman HA, Ali TM, Elesawy BH, Zaky MY. 2022. Cinnamaldehyde mitigates atherosclerosis induced by high-fat diet via modulation of hyperlipidemia, oxidative Stress, and inflammation. Oxid Med Cell Longev. 2022:4464180–4464115. doi:10.1155/2022/4464180.
   PubMed Web of Science ®Google Scholar
• Kannel WB. 2000. Incidence and epidemiology of heart failure. Heart Fail Rev. 5(2):167–173. doi:10.1023/A:1009884820941.
   PubMedGoogle Scholar
• Kim Y, Shrestha R, Kim S, Kim JA, Lee J, Jeong TC, Kim JH, Lee S. 2020. In vitro characterization of glycyrol metabolites in human liver microsomes using HR-resolution MS spectrometer coupled with tandem mass spectrometry. Xenobiotica. 50(4):380–388. doi:10.1080/00498254.2019.1636418.
   PubMed Web of Science ®Google Scholar
• Koc K, Geyikoglu F, Cakmak O, Koca A, Kutlu Z, Aysin F, Yilmaz A, Aşkın H. 2021. The targets of beta-sitosterol as a novel therapeutic against cardio-renal complications in acute renal ischemia/reperfusion damage. Naunyn Schmiedebergs Arch Pharmacol. 394(3):469–479. doi:10.1007/s00210-020-01984-1.
   PubMed Web of Science ®Google Scholar
• Lasley RD. 2018. Adenosine receptor-mediated cardioprotection-current limitations and future directions. Front Pharmacol. 9:310. doi:10.3389/fphar.2018.00310.
   PubMed Web of Science ®Google Scholar
• Li M, Wen Z, Xue Y, Han X, Ma D, Ma Z, Wu Z, Guan S, Sun S, Chu L. 2020. Cardioprotective effects of glycyrrhizic acid involve inhibition of calcium influx via L-type calcium channels and myocardial contraction in rats. Naunyn Schmiedebergs Arch Pharmacol. 393(6):979–989. doi:10.1007/s00210-019-01767-3.
   PubMed Web of Science ®Google Scholar
• Li S, Zhang B. 2013. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Nat Med. 11(2):110–120. doi:10.1016/S1875-5364(13)60037-0.
   PubMed Web of Science ®Google Scholar
• Li Y, Liang Y, Zhu Y, Zhang Y, Bei Y. 2018. Noncoding RNAs in cardiac hypertrophy. J Cardiovasc Transl Res. 11(6):439–449. doi:10.1007/s12265-018-9797-x.
   PubMed Web of Science ®Google Scholar
• Liao Y, Takashima S, Asano Y, Asakura M, Ogai A, Shintani Y, Minamino T, Asanuma H, Sanada S, Kim J, et al. 2003. Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model. Circ Res. 93(8):759–766.,. doi:10.1161/01.RES.0000094744.88220.62.
   PubMed Web of Science ®Google Scholar
• Lu S, Ye L, Yin S, Zhao C, Yan M, Liu X, Cui J, Hu H. 2019. Glycyrol exerts potent therapeutic effect on lung cancer via directly inactivating T-LAK cell-originated protein kinase. Pharmacol Res. 147:104366. doi:10.1016/j.phrs.2019.104366.
   PubMed Web of Science ®Google Scholar
• Luan F, Rao Z, Peng L, Lei Z, Zeng J, Peng X, Yang R, Liu R, Zeng N. 2022. Cinnamic acid preserves against myocardial ischemia/reperfusion injury via suppression of NLRP3/Caspase-1/GSDMD signaling pathway. Phytomedicine. 100:154047. doi:10.1016/j.phymed.2022.154047.
   PubMed Web of Science ®Google Scholar
• Mathoôt RA, Soudijn W, Breimer DD, Ijzerman AP, Danhof M. 1996. Pharmacokinetic-haemodynamic relationships of 2-chloroadenosine at adenosine A1 and A2a receptors in vivo. Br J Pharmacol. 118(2):369–377. doi:10.1111/j.1476-5381.1996.tb15412.x.
   PubMed Web of Science ®Google Scholar
• McIntosh VJ, Lasley RD. 2012. Adenosine receptor-mediated cardioprotection: are all 4 subtypes required or redundant? J Cardiovasc Pharmacol Ther. 17(1):21–33. doi:10.1177/1074248410396877.
   PubMed Web of Science ®Google Scholar
• Monda E, Lioncino M, Pacileo R, Rubino M, Cirillo A, Fusco A, Esposito A, Verrillo F, Di Fraia F, Mauriello A, et al. 2021. Advanced heart failure in special population-pediatric age. Heart Fail Clin. 17(4):673–683.,. doi:10.1016/j.hfc.2021.05.011.
   PubMed Web of Science ®Google Scholar
• Mosterd A, Hoes AW. 2007. Clinical epidemiology of heart failure. Heart. 93(9):1137–1146. doi:10.1136/hrt.2003.025270.
   PubMed Web of Science ®Google Scholar
• Nakamura M, Sadoshima J. 2018. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol. 15(7):387–407. doi:10.1038/s41569-018-0007-y.
   PubMed Web of Science ®Google Scholar
• Nowak R, Drozd M, Mendyk E, Lemieszek M, Krakowiak O, Kisiel W, Rzeski W, Szewczyk K. 2016. A new for the isolation of ergosterol and peroxyergosterol as active compounds of hygrophoropsis aurantiaca and in vitro antiproliferative activity of isolated ergosterol peroxide. Molecules. 21(7):946. doi:10.3390/molecules21070946.
   PubMed Web of Science ®Google Scholar
• Olah ME, Stiles GL. 1995. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu Rev Pharmacol Toxicol. 35(1):581–606. doi:10.1146/annurev.pa.35.040195.003053.
   PubMedGoogle Scholar
• Pasquini S, Contri C, Borea PA, Vincenzi F, Varani K. 2021. Adenosine and inflammation: here, there and everywhere. Int J Mol Sci. 22(14):7685. doi:10.3390/ijms22147685.
   PubMed Web of Science ®Google Scholar
• Peng L, Lei Z, Rao Z, Yang R, Zheng L, Fan Y, Luan F, Zeng N. 2021. Cardioprotective activity of ethyl acetate extract of Cinnamomi ramulus against myocardial ischemia/reperfusion injury in rats via inhibiting NLRP3 inflammasome activation and pyroptosis. Phytomedicine. 95:153863. doi:10.1016/j.phymed.2021.153863.
   PubMed Web of Science ®Google Scholar
• Ribé D, Sawbridge D, Thakur S, Hussey M, Ledent C, Kitchen I, Hourani S, Li JM. 2008. Adenosine A2A receptor signaling regulation of cardiac NADPH oxidase activity. Free Radic Biol Med. 44(7):1433–1442. doi:10.1016/j.freeradbiomed.2007.12.035.
   PubMed Web of Science ®Google Scholar
• Riehle C, Bauersachs J. 2019. Small animal models of heart failure. Cardiovasc Res. 115(13):1838–1849. doi:10.1093/cvr/cvz161.
   PubMed Web of Science ®Google Scholar
• Savarese G, Lund LH. 2017. Global Public Health Burden of Heart Failure. Card Fail Rev. 3(1):7–11. doi:10.15420/cfr.2016:25:2.
   PubMedGoogle Scholar
• Scarborough EA, Uchida K, Vogel M, Erlitzki N, Iyer M, Phyo SA, Bogush A, Kehat I, Prosser BL. 2021. Microtubules orchestrate local translation to enable cardiac growth. Nat Commun. 12(1):1547. doi:10.1038/s41467-021-21685-4.
   PubMed Web of Science ®Google Scholar
• Sedighi M, Nazari A, Faghihi M, Rafieian-Kopaei M, Karimi A, Moghimian M, Mozaffarpur SA, Rashidipour M, Namdari M, Cheraghi M, et al. 2018. Protective effects of cinnamon bark extract against ischemia-reperfusion injury and arrhythmias in rat. Phytother Res. 32(10):1983–1991. doi:10.1002/ptr.6127.
   PubMed Web of Science ®Google Scholar
• Szentmiklosi AJ, Galajda Z, Cseppento Á, Gesztelyi R, Susán Z, Hegyi B, Nánási PP. 2015. The Janus face of adenosine: antiarrhythmic and proarrhythmic actions. Curr Pharm Des. 21(8):965–976. doi:10.2174/1381612820666141029100346.
   PubMed Web of Science ®Google Scholar
• Tanaka N, Dalton N, Mao L, Rockman HA, Peterson KL, Gottshall KR, Hunter JJ, Chien KR, Ross J. 1996. Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation. 94(5):1109–1117. doi:10.1161/01.cir.94.5.1109.
   PubMed Web of Science ®Google Scholar
• Tian J, Shan XL, Wang SN, Chen HH, Zhao P, Qian DD, Xu M, Guo W, Zhang C, Lu R. 2022. Trans-cinnamaldehyde suppresses microtubule detyrosination and alleviates cardiac hypertrophy. Eur J Pharmacol. 914:174687. doi:10.1016/j.ejphar.2021.174687.
   PubMed Web of Science ®Google Scholar
• Upadhyay S, Mantha AK, Dhiman M. 2020. Glycyrrhiza glabra (Licorice) root extract attenuates doxorubicin-induced cardiotoxicity via alleviating oxidative stress and stabilising the cardiac health in H9c2 cardiomyocytes. J Ethnopharmacol. 258:112690. doi:10.1016/j.jep.2020.112690.
   PubMed Web of Science ®Google Scholar
• Wakeno M, Minamino T, Seguchi O, Okazaki H, Tsukamoto O, Okada K-i, Hirata A, Fujita M, Asanuma H, Kim J, et al. 2006. Long-term stimulation of adenosine A2b receptors begun after myocardial infarction prevents cardiac remodeling in rats. Circulation. 114(18):1923–1932. doi:10.1161/CIRCULATIONAHA.106.630087.
   PubMedGoogle Scholar
• Wong HS, Chen N, Leong PK, Ko KM. 2014. β-Sitosterol enhances cellular glutathione redox cycling by reactive oxygen species generated from mitochondrial respiration: protection against oxidant injury in H9c2 cells and rat hearts. Phytother Res. 28(7):999–1006. doi:10.1002/ptr.5087.
   PubMed Web of Science ®Google Scholar
• Xu J, Bian X, Liu Y, Hong L, Teng T, Sun Y, Xu Z. 2017. Adenosine A2 receptor activation ameliorates mitochondrial oxidative stress upon reperfusion through the posttranslational modification of NDUFV2 subunit of complex I in the heart. Free Radic Biol Med. 106:208–218. doi:10.1016/j.freeradbiomed.2017.02.036.
   PubMed Web of Science ®Google Scholar
• Xu Z, Jin Y, Gao Z, Zeng Y, Du J, Yan H, Chen X, Ping L, Lin N, Yang B, et al. 2022. Autophagic degradation of CCN2 (cellular communication network factor 2) causes cardiotoxicity of sunitinib. Autophagy. 18(5):1152–1173. doi:10.1080/15548627.2021.1965712.
   PubMed Web of Science ®Google Scholar
• Ye H, Wei J, Tang K, Feuers R, Hong H. 2016. Drug repositioning through network pharmacology. Curr Top Med Chem. 16(30):3646–3656. doi:10.2174/1568026616666160530181328.
   PubMed Web of Science ®Google Scholar
• Yip KH, Lau HY, Wise H. 2011. Reciprocal modulation of anti-IgE induced histamine release from human mast cells by A1 and A2B adenosine receptors. Br J Pharmacol. 164(2b):807–819. doi:10.1111/j.1476-5381.2011.01446.x.
   PubMed Web of Science ®Google Scholar
• Zangi L, Lui KO, von Gise A, Ma Q, Ebina W, Ptaszek LM, Später D, Xu H, Tabebordbar M, Gorbatov R, et al. 2013. Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction. Nat Biotechnol. 31(10):898–907. doi:10.1038/nbt.2682.
   PubMed Web of Science ®Google Scholar
• Zhai YJ, Liu P, He HR, Zheng XW, Wang Y, Yang QT, Dong YL, Lu J. 2015. The association of ADORA2A and ADORA2B polymorphisms with the risk and severity of chronic heart failure: a case-control study of a northern Chinese population. Int J Mol Sci. 16(2):2732–2746. doi:10.3390/ijms16022732.
   PubMed Web of Science ®Google Scholar
• Zhan E, McIntosh VJ, Lasley RD. 2011. Adenosine A2A and A2B receptors are both required for adenosine A1 receptor-mediated cardioprotection. Am J Physiol Heart Circ Physiol. 301(3):H1183–1189. doi:10.1152/ajpheart.00264.2011.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wernly B, Cao X, Mustafa SJ, Tang Y, Zhou Z. 2021. Adenosine and adenosine receptor-mediated action in coronary microcirculation. Basic Res Cardiol. 116(1):22. doi:10.1007/s00395-021-00859-7.
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhang H, Li N, Chen J, Xu H, Wang Y, Liang Q. 2023. Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula. J Ethnopharmacol. 309:116306. doi:10.1016/j.jep.2023.116306.
   PubMed Web of Science ®Google Scholar